CRUK SACT regimen-specific consent form project

The CRUK SACT regimen-specific consent form project team is pleased to announce that a number of consent forms have been developed and published. They are now available on the CRUK website at: www.cruk.org/sact_consent.

 

  • Children and Young Persons Acute Lymphoblastic Leukaemia / Lymphoma
  • Kaposi Sarcoma
    • Consent forms for docetaxel and liposomal daunorubicin (DaunoXome) have been archived
  • CML
    • A consent form for asciminib has been added
  • GIST
  • AML
    • Azacitidine oral option added to consent form
  • Vinorelbine Update
    • Timelines for contraception amended in vinorelbine-containing consent forms in accordance with updated manufacturers guidance
    • Affected forms: vinorelbine oral (breast), vinorelbine oral, vinorelbine IV, vinorelbine-cisplatin, vinorelbine-carboplatin (lung). Vinorelbine IV and vinorelbine-capecitabine (breast) will be updated as part of group revalidation currently underway
  • Generic Updates
    • Fertility and pregnancy statements have been updated to utilise inclusive and gender neutral language
    • Risk of viral infection worsening or re-activation in line with the UK SACT Board position statement (2022)

 

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

 

Best Wishes,

Lucy

 

Lucy Cox

Cancer Research UK Specialist Pharmacist – Cancer Information Lead

Guy’s and St Thomas’ NHS Foundation Trust

Guy’s Hospital, Great Maze Pond, London, SE1 9RT

www.cancer.org.uk/sact_consent

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article